#United States #New York #Class Action #Gross Law Firm #Telix Pharmaceuticals

Important Reminder for Telix Pharmaceuticals Shareholders

The Gross Law Firm is reaching out to shareholders of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) amid an ongoing lawsuit that could impact many investors. If you purchased shares in Telix during the class period from February 21, 2025, to August 28, 2025, it is crucial to be aware that the deadline to apply for lead plaintiff status is quickly approaching. January 9, 2026, marks the last day to register as a lead plaintiff in this lawsuit.

Understanding the Allegations

This case highlights serious allegations against Telix Pharmaceuticals. Investors are encouraged to contact the Gross Law Firm for more details about the class action lawsuit. According to the complaint, the defendants allegedly made materially false or misleading statements regarding the company's performance related to prostate cancer treatment developments. Specific claims include:

• - Overstating the progress on therapeutic candidates for prostate cancer.
• - Misrepresenting the quality of Telix’s supply chain and partnerships.
• - Consequently, making statements regarding Telix's business operations that were fundamentally misleading and lacked a reasonable basis at all times.

These allegations suggest that Telix's stock may have been artificially inflated due to these misleading statements, leading to potential losses for investors once the truth came to light.

Next Steps for Shareholders

For any shareholder eligible to participate in this class action, registering your interest with Gross Law Firm is the first step. Upon registration, participants will have access to a portfolio monitoring software that offers updates regarding the case's progress. Notably, registering does not prevent individuals from being considered for lead plaintiff status, nor does it come with any fees or obligations.

Benefits of Participation

Engaging in this class action lawsuit may provide you with avenues for recovery of your investment losses. The Gross Law Firm stands committed to protecting the rights of investors harmed by deceptive or illegal business practices. Their mission is to hold companies accountable and seek recovery on behalf of those who have suffered from misleading corporate actions.

Why Choose Gross Law Firm?

The Gross Law Firm has established itself as a leading voice in advocating for investors. Their commitment extends beyond litigation; it is focused on ensuring that businesses operate ethically and uphold their responsibilities to investors. The firm's achievements demonstrate their ability to effectively navigate complex legal landscapes, bringing justice to investors who have been wronged.

Contact Information

Shareholders interested in learning more or wishing to participate in this lawsuit can contact the Gross Law Firm directly. Here are the contact details:

• - Address: 15 West 38th Street, 12th Floor, New York, NY, 10018
• - Email: [email protected]
• - Phone: (646) 453-8903

Remember, the registration deadline for potential lead plaintiffs is January 9, 2026. Don’t miss your opportunity to participate in this class action and stand up for your rights as an investor. Ensuring a fair resolution is critical not only for personal investment recovery but also for maintaining the integrity of the financial market.

Stay informed and proactive to safeguard your investments.